New ICH Guide To Eliminate ‘Discordant Advice’ On Juvenile Animal Studies
Experts at the International Council for Harmonisation have nearly completed the first draft of a guideline that explains in which situations nonclinical juvenile animal testing is considered informative and necessary to support pediatric drug development. The guideline is expected to address the "discordant advice" that different regulatory agencies currently offer companies in relation to such studies.
You may also be interested in...
A new international guideline on non-clinical safety testing in support of pediatric drug development aims to cut unnecessary use of animals.
Europe’s research-based pharmaceutical industry has suggested changes to the draft ICH S11 guideline on nonclinical safety studies for supporting pediatric development programs.
The Canadian authorities have put in place an expedited pathway for authorizing new COVID-19 drugs and vaccines that offers a more agile approach to reviewing data than what was previously allowed.